Advanced Search

Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 December;59(4)

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUETHE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

A Journal on Nuclear Medicine and Molecular Imaging

A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413

Frequency: Quarterly

ISSN 1824-4785

Online ISSN 1827-1936

 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 December;59(4)

DIAGNOSTIC AND THERAPEUTIC MANAGEMENT OF LOCALLY ADVANCED AND ADVANCED PROSTATE CANCER 

     EDITORIAL

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 December;59(4):357-8

Role of of Nuclear Medicine in the multidisciplinary management of prostate cancer

Ceresoli G. L., Bombardieri E.


     REVIEWS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 December;59(4):359-73

Early detection of prostate cancer relapse by biochemistry and diagnostic imaging

Evangelista L., Zattoni F., Rossi E., Karnes R. J., Lowe V.


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 December;59(4):374-80

Role of chemotherapy in combination with hormonal therapy in first-line treatment of metastatic hormone-sensitive prostate cancer

Ceresoli G. L., De Vincenzo F., Sauta M. G., Bonomi M., Zucali P. A.


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 December;59(4):381-99

Which metabolic imaging, besides bone scan with 99mTc-phosphonates, for detecting and evaluating bone metastases in prostatic cancer patients? An open discussion

Bombardieri E., Setti L., Kirienko M., Antunovic L., Guglielmo P., Ciocia G.


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 December;59(4):400-10

Improvement in survival and quality of life with new therapeutic agents in metastatic castration-resistant prostate cancer: comparison among the results

Recine F., Ceresoli G. L., Baciarello G., Cerbone L., Calabrò F.


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 December;59(4):411-9

Lymph-node relapsed prostate cancer management and PET-driven external beam radiotherapy: salvage or palliative treatment?

Vavassori V., Alongi F., D’agostino G. A., Della Bosca E., Scorsetti M.


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 December;59(4):420-38

New radiopharmaceutical agents for the treatment of castration-resistant prostate cancer

Maffioli L., Florimonte L., Costa D. C., Correia Castanheira J., Grana C., Luster M., Bodei L., Chinol M.


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 December;59(4):439-45

Prostate cancer as a chronic disease: cost-effectiveness and proper follow-up

Guttilla A., Bortolami A., Evangelista L.


     ORIGINAL ARTICLES

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 December;59(4):446-54

Fluorodeoxyglucose positron emission tomography in pulmonary carcinoid tumors

Gasparri R., Rezende G. C., Fazio N., Maisonneuve P., Brambilla D., Travaini L. L., Paganelli G., Petrella F., Galetta D., Spaggiari L.


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 December;59(4):455-61

A quantitive study about thyroid stunning after diagnostic whole-body scanning with 74 MBq 131I in patients with differentiated thyroid carcinoma

Yin Y., Mao Q., Chen S., Li N., Li X., Li Y.


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 December;59(4):462-8

Reproducibility of FDG PET based metabolic tumor volume measurements and of their FDG distribution within

Kruse V., Mees G., Maes A., D’asseler Y., Borms M., Cocquyt V., Van De Wiele C.


top of page